Pharmaceutical

Astellas and PeptiDream enter protein degrader discovery deal

Astellas Pharma has entered a research partnership and licence agreement with PeptiDream for the discovery of new targeted protein degraders.

Jul 25, 2023 - 20:00
Astellas and PeptiDream enter protein degrader discovery deal
Astellas Pharma has entered a research partnership and licence agreement with PeptiDream for the discovery of new targeted protein degraders.
Read the original article

Tags:

Previous Article

Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch

Next Article

Alvotech and Teva step up biosimilars partnership

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Codiak BioSciences gets grant for extracellular vesicle...

Aug 23, 2024

STAT+: NIH systems for non-human primate research fall short, threatening biomedical research

STAT+: NIH systems for non-human primate research fall ...

May 5, 2023

STAT+: Pharmalittle: U.K. regulator to streamline clinical trial approvals; NIH won’t seize patents to cut price of cancer drug

STAT+: Pharmalittle: U.K. regulator to streamline clini...

Mar 22, 2023